Lung and Esophageal Surgeon Rodney Landreneau, M.D., Joins

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lung and Esophageal Surgeon Rodney Landreneau, M.D., Joins Allegheny Health Network

PITTSBURGH, Pa., Oct. 8, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Rodney J. Landreneau, MD, a nationally recognized thoracic surgeon known for his expertise in the treatment of advanced diseases of the lung and esophagus, has returned to Pittsburgh to join the Allegheny Health Network.

Dr. Landreneau, who most recently served as Medical Director of the Ochsner Health System Cancer Institute in New Orleans, brings to Allegheny Health Network a long and distinguished career of pioneering leadership and innovation in thoracic surgery, surgical oncology and clinical research.

He will serve as Division Director of General Thoracic Surgery for the Network, as well as System Director of Thoracic Oncology and Co-Director of its Esophageal and Lung Institute. His surgical practice will be based at Allegheny General Hospital and West Penn Hospital.

Prior to joining Ochsner, Dr. Landreneau spent more than two decades at the University of Pittsburgh Medical Center, where he directed the lung cancer program and performed the world's first minimally invasive lung resection. He served as co-director of the cardiac transplantation program at the University of Missouri before coming to Pittsburgh in the early 1990s to lead the Department of Thoracic Surgery at Allegheny General Hospital.

"I'm very excited to join Allegheny Health Network's patient-focused and physician-led healthcare team," Dr. Landreneau said. "I believe it is the ideal setting to pursue continued excellence and innovation in the surgical treatment of thoracic disease and look forward to working with the Network's outstanding group of physicians and support staff to help further build the Esophageal and Lung Institute into one of the country's foremost programs."

Dr. Landreneau specializes in treating patients with lung and esophageal diseases, including gastroesophageal reflux disease (GERD), lung cancer, esophageal cancer and pleural mesothelioma, a rare and often-fatal cancer often diagnosed in people who have been exposed to high levels of asbestos. He is particularly noted for his expertise in the use of advanced, minimally invasive surgical techniques.

He is also one of only a few doctors nationwide performing a breakthrough mesothelioma therapy known as hyperthermic intraperitoneal chemoperfusion (HIPEC). The procedure involves surgically removing all visible signs of cancer before heated chemotherapy drugs are introduced directly into the chest cavity.

"We are thrilled to welcome Dr. Landreneau back to our organization," said George J. Magovern, MD, Professor and Chairman of Allegheny Health Network's Department of Thoracic and Cardiovascular Surgery . "He is among the world's preeminent thoracic surgeons whose long history of innovation and outstanding clinical work has benefited countless patients with lung and esophageal disease. Under the leadership of Drs. Landreneau and Blair Jobe, we are strongly positioned to be one of the country's premiere referral centers in this highly specialized field."

Dr. Jobe, widely recognized his groundbreaking research and advanced treatments for esophageal disease, joined Allegheny Health Network in 2013 as Director of its Esophageal and Lung Institute, a comprehensive, multidisciplinary clinical and research program. The Institute is on the forefront of cutting-edge diagnostic and treatment options for the complete spectrum of thoracic and esophageal diseases.

"Few thoracic surgeons in the world have helped revolutionize our field more over the past two decades than Rodney Landreneau. He is a transformative, exceptionally dedicated clinician and medical pioneer whose new role at Allegheny Health Network significantly elevates our lung and esophageal disease program as a leading provider of advanced, patient-centered care," Dr. Jobe said.

A graduate of Louisiana State University and its School of Medicine, Dr. Landreneau served his residency in general surgery at Parkland Memorial Hospital in Dallas and his residency in thoracic surgery at the University of Michigan Medical Center.

Named numerous times to Pittsburgh Magazine's list of the region's Top Doctors, Dr. Landreneau holds specialty certifications from the American Board of Surgery and the American Board of Thoracic Surgery. He also is a member of the American Surgical Association, considered the world's most exclusive and premiere surgical society, and has authored or co-authored more than 500 peer-reviewed scientific journal articles and book chapters.

A resident of Wexford, PA where he lives with his wife Sandy, 11 year-old daughter and twin 6 year-old sons, Dr. Landreneau is also the father of four older children, a son who works as an electrical engineer in Houston, a son who is a nuclear engineer in Connecticut and two sons in medical schools; and the grandfather of two.

For more information or to make an appointment with Dr. Landreneau or Dr. Jobe, call 412-DOCTORS (362-8677), visit http://www.ahn.org/appointments or call the Esophageal and Thoracic Institute at 724.260.7300.

About the Allegheny Health Network:

Allegheny Health Network is an integrated healthcare delivery system serving the Western Pennsylvania region. The Network is comprised of eight hospitals, including its flagship academic medical center Allegheny General Hospital, Allegheny Valley Hospital, Canonsburg Hospital, Forbes Hospital, Jefferson Hospital, Saint Vincent Hospital, Westfield Memorial Hospital and West Penn Hospital; the Allegheny-Singer Research Institute; Health + Wellness Pavilions; and a healthcare group purchasing organization. The Network employs approximately 17,000 people, including more than 2,100 physicians on its medical staff. The Network also serves as a clinical campus for both Temple University School of Medicine and Drexel University College of Medicine.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/10/prweb12232674.htm

Allegheny Health Network Dan Laurent +1 412-807-8103

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 16

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 150

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 132

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 127

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 115

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 91

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 28

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Stellus PBDC's Q3: Solid Income but NAV Drops

Updated Category News Views 208

Stellus PBDC: Q3 Earnings and Strategic Moves Things are getting interesting in Houston where Stellus Private Credit BDC just laid out its financial cards for the third quarter of 2026. Now, I’ve seen my fair share of quarterly reports, but Stellus seems to have stitched a quilt of mixed results this time around. Investment Income and Portfolio Shifts First off, net...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 213

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading

Top 5 Most Recently Viewed Articles

PHX Minerals Set to Release Full-Year 2024 Financial Results

Updated Category News Views 176

PHX Minerals Reveals Upcoming Financial Results Announcement PHX MINERALS INC., commonly known as PHX, is preparing to share its financial results for the year that concluded on December 31, 2024. This announcement is eagerly awaited by investors and stakeholders, marking a significant moment in understanding the company’s financial health and future outlook. Details of...

Continue Reading
Baird Optimistic on First Industrial Realty Trust Growth Ahead

Updated Category News Views 183

Baird's Positive Outlook for First Industrial Realty Trust Baird has reaffirmed its positive stance on First Industrial Realty Trust (NYSE: FR), maintaining an Outperform rating alongside a $61.00 price target. The firm's analysis indicates that the company's core portfolio is projected to deliver a stable 6% annual growth, signaling strong performance prospects for...

Continue Reading
Aprea Therapeutics Secures $3.1 Million Investment for Growth

Updated Category News Views 151

Aprea Therapeutics Secures $3.1 Million Investment Aprea Therapeutics, Inc. (Nasdaq: APRE), a forward-thinking clinical-stage biopharmaceutical company, has announced a notable private placement aimed at enhancing its development of innovative cancer treatments. This financing comes from a blend of new and existing investors, reflecting confidence in the company’s...

Continue Reading
Silal and SVG Forge New Paths in Sustainable Agriculture

Updated Category News Views 174

Silal and SVG Forge New Paths in Sustainable Agriculture In a significant development for the agricultural sector, Silal, a leading agri-food and technology company, and Shouguang Colorful Manor Modern Agriculture Co., Ltd (SVG) have entered a joint venture that stands to revolutionize sustainable agriculture practices. This landmark agreement was witnessed by eminent...

Continue Reading